Kaye Edward M. MD 4

What Happened
Edward M. Kaye, MD — a director of Cytokinetics, Inc. (CYTK) — disposed of 2,933 shares in an open-market sale on 2026-06-01 at $76.09 per share, generating proceeds of approximately $223,172. This was a sale (transaction code S), which is often a routine insider disposition rather than a signal of company fundamentals.

Key Details

• Transaction date: 2026-06-01
• Transaction type: Open-market sale (Code S)
• Shares sold: 2,933 at $76.09 each; proceeds ≈ $223,171.97 ($223,172)
• Shares owned after transaction: Not specified in the provided filing — see the Form 4 for total holdings
• Footnotes/plan: No 10b5-1 plan, tax-withholding, or other footnote disclosed in the summary provided
• Filing timeliness: Report filed on 2026-06-01 (same day as reported transaction); no late filing indicated in the supplied details

Context
Sales by company directors can be routine (portfolio rebalancing, liquidity needs, estate planning) and do not by themselves indicate insider sentiment about the company. This filing reports an outright sale of common stock; there is no indication here of option exercises, gifts, or other derivative transactions. For complete holding history and disclosures, consult the full Form 4 (accession 0001061983-26-000066).